AstraZeneca: all 4,196 studies
Page 24 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)CompletedNCT04031898
- Stage III NSCLC RWE in Chinese PatientsCompletedNCT04023812
- CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)WithdrawnNCT04021082Phase 2/3
- Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594CompletedNCT04002427Phase 1
- Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes MellitusWithdrawnNCT04001231Phase 1
- Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBCActive, not recruitingNCT03997123Phase 3
- Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLCCompletedNCT03995875
- A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult SubjectsCompletedNCT03989544Phase 1
- A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid MalignanciesCompletedNCT03980821Phase 1
- A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With AsthmaCompletedNCT03976869Phase 1
- A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.TerminatedNCT03971110Phase 4
- Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A Descriptive Analysis of the Asthma Patient Population in the Emirate of Dubai With Respect to Healthcare Resource Utilization, Costs, and Asthma-related Treatment PatternCompletedNCT03963141
- Benralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsCompletedNCT03953300Phase 4
- Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in VolunteersCompletedNCT03948451Phase 1
- A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid TumorsCompletedNCT03946800Phase 1
- Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)Active, not recruitingNCT03944772Phase 2
- A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)CompletedNCT03934333Phase 1
- Prevalence of the Eosinophilic Phenotype Among Severe Asthma PatientsCompletedNCT03931954
- Pharmacokinetic Study of Benralizumab in Healthy Chinese SubjectsCompletedNCT03928262Phase 1
- BRazilian Asthmatics Patients EOSinophilic Profile (BRAEOS)CompletedNCT03925415
- Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402CompletedNCT03921268Phase 1
- Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUSCompletedNCT03918304
- Real World Study With Benralizumab in Severe Asthma in SwitzerlandCompletedNCT03907137
- A Scintigraphy Study of PT010 in COPD PatientsCompletedNCT03906045Phase 1
- Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat InfluenzaWithdrawnNCT03903718Phase 2
- A Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsCompletedNCT03889275Phase 1
- Prevalence of Asthma and Allergies Among Children in UAECompletedNCT03878680
- SABINA INTERNATIONALCompletedNCT03857178
- Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative TreatmentCompletedNCT03847428Phase 3
- A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy VolunteersCompletedNCT03843060Phase 1
- A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese SubjectsCompletedNCT03836599Phase 1
- Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLLActive, not recruitingNCT03836261Phase 3
- Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR MutationActive, not recruitingNCT03833154Phase 3
- Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.CompletedNCT03833141
- A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLCActive, not recruitingNCT03819465Phase 1
- A Disease Registry of Patients With Mantle Cell LymphomaCompletedNCT03816683
- A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsCompletedNCT03811652Phase 1
- A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male SubjectsCompletedNCT03804645Phase 1
- Assessment of Asthma Control Level in Primary Care Setting in MalaysiaCompletedNCT03804632
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Japanese Healthy Participants With Single and Multiple Ascending Dose AdministrationCompletedNCT03801967Phase 1
- A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung CancerActive, not recruitingNCT03800134Phase 3
- First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After ChemoradiotherapyCompletedNCT03798535
- Benralizumab Pregnancy Exposure StudyTerminatedNCT03794999
- Prevalence of PD-L1 Expression in Patients With Advanced Urothelial CarcinomaCompletedNCT03788746
- A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular CarcinomaActive, not recruitingNCT03778957Phase 3
- A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.CompletedNCT03772223Phase 1
- Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in BelgiumCompletedNCT03761901
- A Phase 1 Study of [225Ac]-FPI-1434 InjectionTerminatedNCT03746431Phase 1
- A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol FumarateCompletedNCT03740373Phase 1
- A Phase I Study of MEDI9447 (Oleclumab) in Japanese PatientsCompletedNCT03736473Phase 1
- A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer PatientsCompletedNCT03725475
- Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer PatientsCompletedNCT03721289
- AZD4635 Relative Bioavailability StudyCompletedNCT03710434Phase 1
- Characteristics of Patients With Type 2 Diabetes Mellitus (CVD-RNDR)CompletedNCT03694470
- Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum PotassiumTerminatedNCT03682497Phase 1
- Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial CancerActive, not recruitingNCT03682068Phase 3
- To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.WithdrawnNCT03658213Phase 3
- Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE)CompletedNCT03657875
- Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes MellitusCompletedNCT03654313Phase 1
- ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in MoscowCompletedNCT03654157
- A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male ParticipantsCompletedNCT03649165Phase 1
- A Study of SYNT001 in Healthy VolunteersCompletedNCT03643627Early Phase 1
- IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation TherapyCompletedNCT03643484
- The Study for Evaluating Factors Relating to Daily Step Counts and Physical Activity in Japanese Patients With COPD.CompletedNCT03642613
- Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in ChinaCompletedNCT03633838
- Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological TherapyCompletedNCT03629782
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese ParticipantsCompletedNCT03625778Phase 1
- DAPA - Egypt StudyCompletedNCT03624803
- Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.Active, not recruitingNCT03616587Phase 1
- BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding OutcomesWithdrawnNCT03613402
- Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/SaxagliptinTerminatedNCT03608358Phase 3
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.CompletedNCT03593785Phase 1
- Lynparza Breast Cancer Clinical Experience InvestigationCompletedNCT03590938
- FASENRA SCEI for Long-term UseCompletedNCT03588546
- ALEXANDRIA Study EgyptCompletedNCT03583463
- A Prospective Cohort Study of Asthma and COPD Overlap in Japanese COPD Patients Using the Diagnostic Criteria of The Japanese Respiratory SocietyCompletedNCT03577795
- A Ph 1 Study of Epanova® in Healthy ChinesesCompletedNCT03574142Phase 1
- Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).CompletedNCT03562819
- S-CEI of Nexium in Paediatric PatientsCompletedNCT03562026
- Development of AECOPD Identification Tool (DETECT Study)CompletedNCT03556475
- Study of Danicopan in Participants With Hepatic ImpairmentCompletedNCT03555539Phase 1
- A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.CompletedNCT03553108Phase 1
- A Study to Evaluate MEDI5752 in Subjects With Advanced Solid TumorsActive, not recruitingNCT03530397Phase 1
- Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder CancerActive, not recruitingNCT03528694Phase 3
- Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)CompletedNCT03527147Phase 1
- Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong KongWithdrawnNCT03519958
- Prospective Tissue Collection Research ProtocolCompletedNCT03517917
- Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsCompletedNCT03509012Phase 1
- Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation)CompletedNCT03505307
- An Early Access Programme for Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell LeukemiaApproved for marketingNCT03501615
- PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)CompletedNCT03492931Phase 1
- Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid TumorsCompletedNCT03490669Phase 1
- MEDI2228 in Subjects With Relapsed/Refractory Multiple MyelomaCompletedNCT03489525Phase 1
- A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC PatientsCompletedNCT03485326
- Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in IndiaCompletedNCT03471572
- An Observational Study to Evaluate AZD9291 Treatment in Patients With T790M Positive Non-small Cell Lung CancerCompletedNCT03457220
- A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male SubjectsCompletedNCT03450759Phase 1
- ADHERE-S (NIS Brilique)CompletedNCT03444012
- A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants.CompletedNCT03436316Phase 1
- Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male SubjectsCompletedNCT03435276Phase 1